Advocacy
The Canadian Headache Society's advocacy efforts include the following:
​​
-
Leading the development and dissemination of national clinical guidelines, and sharing scientific literature and evidence to support best practices and standards of care in headache medicine.
-
Providing and promoting education programs to health care professionals.
-
Contributing to Canadian processes for the assessment of drugs and technologies (CDA reports).
-
Supporting patient-led initiatives through collaborations with Migraine Canada, Migraine Quebec, and Spinal CSF Leaks Canada.
-
Informing relevant stakeholders of the importance of migraine, its burden and the relevance of treating it for Canadians.
-
Assisting providers in finding suitable accommodations for their patients and advocating for the implementation of medical best practices whenever possible.
-
Advocating for increased access to medicines with both public and private payers, in line with evolving clinical data and expertise in headache medicine.
Key principles guiding our actions
Patient outcomes, improvement in health and quality of life
01
Careful evaluation of commercial bias
03
Scientific evidence based on the highest standards or research
02
A fair and balanced approach to all actions
04
CHS Advocacy Committee
​Dr Elizabeth Leroux
Montreal, QC​
​​
​Dr Alex Melinyshyn
London, ON
​​
​​​Dr Danny Monsour
Toronto, ON
​​
Dr Will Kingston
Toronto, ON​
​​
Christie Tait
Toronto, ON​
​​
Wendy Gerhart
Barrie, ON​
​​